Organon (OGN) Retained Earnings (2020 - 2026)

Organon (OGN) posted quarterly Retained Earnings of -$539.0 million for Q1 2026, down 152.53% year-over-year from $1.0 billion in Q1 2025, and down 148.6% on a QoQ basis from $1.1 billion in Q4 2025.

Organon (OGN) Retained Earnings (2020 - 2026) Analysis & Trends

Organon (OGN) has reported Retained Earnings for 7 consecutive years, with -$539.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Retained Earnings fell 152.53% year-over-year to -$539.0 million; the TTM figure through Mar 2026 stood at -$539.0 million (down 152.53% YoY), while the FY2025 annual figure was $1.1 billion, up 270.88% from the prior year.
  • Retained Earnings came in at -$539.0 million for Q1 2026 at Organon, down from $1.1 billion in the prior quarter.
  • The five-year high for Retained Earnings was $1.3 billion in Q3 2025, with the low at -$649.0 million in Q4 2024.
  • Average Retained Earnings over 5 years is -$28.9 million, with a median of -$529.0 million recorded in 2022.
  • Across the five-year window, Retained Earnings tumbled 3468.75% in 2024 and soared 330.82% in 2025, its largest moves.
  • Year by year, Retained Earnings stood at -$564.0 million in 2022, then soared by 178.55% to $443.0 million in 2023, then slumped by 246.5% to -$649.0 million in 2024, then soared by 270.88% to $1.1 billion in 2025, then slumped by 148.6% to -$539.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$539.0 million, $1.1 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 29.51 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -14.83 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -17.87 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 9.67 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 66.72 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -190.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 78.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -7.20 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn -539.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -539.00 Mn
Dec 31, 2025 1.11 Bn
Sep 30, 2025 1.32 Bn
Jun 30, 2025 1.16 Bn
Mar 31, 2025 1.03 Bn
Dec 31, 2024 -649.00 Mn
Sep 30, 2024 -571.00 Mn
Jun 30, 2024 -612.00 Mn
Mar 31, 2024 -577.00 Mn
Dec 31, 2023 443.00 Mn
Sep 30, 2023 -16.00 Mn
Jun 30, 2023 -25.00 Mn
Mar 31, 2023 -534.00 Mn
Dec 31, 2022 -564.00 Mn
Sep 30, 2022 -383.00 Mn
Jun 30, 2022 -551.00 Mn
Mar 31, 2022 -529.00 Mn
Dec 31, 2021 -513.00 Mn
Sep 30, 2021 -493.00 Mn
Jun 30, 2021 81.00 Mn